Zembrace SymTouch Side Effects Center

Last updated on RxList: 3/30/2017
Zembrace SymTouch Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

Last reviewed on RxList 03/30/2017

Zembrace SymTouch (sumatriptan succinate) Injection is a serotonin (5-HT1B/1D) receptor agonist (triptan) indicated for acute treatment of migraine with or without aura in adults. Common side effects of Zembrace SymTouch include:

  • injection site reactions,
  • tingling,
  • dizziness,
  • spinning sensation (vertigo),
  • warm/hot sensation,
  • burning sensation,
  • feeling of heaviness,
  • pressure sensation,
  • flushing,
  • feeling of tightness,
  • numbness,
  • feeling strange,
  • tight feeling in head,
  • chest discomfort,
  • tightness or pressure in chest,
  • sore throat,
  • sinus irritation,
  • jaw discomfort,
  • weakness,
  • neck pain or stiffness,
  • muscle pain,
  • drowsiness,
  • headache, or
  • sweating.

The dose of Zembrace SymTouch for acute treatment of migraine is a single 3 mg dose. Zembrace SymTouch may interact with ergot-containing drugs, monoamine oxidase inhibitors (MAOIs), other 5-HT1agonists (e.g., triptans), selective serotonin reuptake inhibitors (SSRIs), and serotonin norepinephrine reuptake inhibitors (SNRIs). Tell your doctor all medications and supplements you use. Zembrace SymTouch is not recommended for use during pregnancy; it may harm a fetus. Zembrace SymTouch passes into breast milk. Avoid breastfeeding for 12 hours after treatment with Zembrace SymTouch Injection.

Our Zembrace SymTouch (sumatriptan succinate) Injection Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


Who suffers more frequently from migraine headaches? See Answer
Zembrace SymTouch Consumer Information

1 pharmacies near 20147 have coupons for Imitrex (Brand Names:Zembrace-SymTouch for 50MG)

Wegmans Food Markets Inc
Wegmans Food Markets Inc

Est. Regular Price


with free coupon

View Coupon

Get emergency medical help if you have signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Stop using sumatriptan and call your doctor at once if you have:

  • sudden and severe stomach pain and bloody diarrhea;
  • severe chest pain, shortness of breath, irregular heartbeats;
  • a seizure (convulsions);
  • blood circulation problems in your legs or feet--cramps, tight or heavy feeling, numbness or tingling, muscle weakness, burning pain, cold feeling, color changes (pale or blue), hip pain;
  • heart attack symptoms--chest pain or pressure, pain spreading to your jaw or shoulder, nausea, sweating;
  • high levels of serotonin in the body--agitation, hallucinations, fever, fast heart rate, overactive reflexes, nausea, vomiting, diarrhea, loss of coordination, fainting;
  • increased blood pressure--severe headache, blurred vision, pounding in your neck or ears, anxiety, nosebleed; or
  • signs of a stroke--sudden numbness or weakness (especially on one side of the body), sudden severe headache, slurred speech, problems with vision or balance.

Common side effects may include:

  • numbness, tingling, warmth, redness, or burning sensation;
  • pressure or heavy feeling in any part of your body;
  • dizziness, drowsiness, feeling weak or tired;
  • neck pain or stiffness; or
  • pain or redness where the medicine was injected.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Zembrace SymTouch (Sumatriptan Succinate Subcutaneous Injection, USP)


16 Surprising Headache Triggers and Tips for Pain Relief See Slideshow
Zembrace SymTouch Professional Information


The following serious adverse reactions are described below and elsewhere in the labeling:

Clinical Trials Experience

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of another drug and may not reflect the rates observed in practice.

Migraine Headache

Table 1 lists adverse reactions that occurred in 2 US placebo-controlled clinical trials in migraine subjects (Studies 2 and 3), following either a single 6-mg dose of sumatriptan injection or placebo. Only reactions that occurred at a frequency of 2% or more in groups treated with sumatriptan injection 6 mg and that occurred at a frequency greater than the placebo group are included in Table 1.

Table 1: Adverse Reactions in Pooled Placebo-Controlled Trials in Patients with Migraine (Studies 2 and 3)

Adverse Reaction Percent of Subjects Reporting
Sumatriptan Injection 6 mg Subcutaneous
(n = 547)
(n = 370)
Atypical sensations 42 9
  Tingling 14 3
  Warm/hot sensation 11 4
  Burning sensation 7 < 1
  Feeling of heaviness 7 1
  Pressure sensation 7 2
  Feeling of tightness 5 < 1
  Numbness 5 2
  Feeling strange 2 < 1
  Tight feeling in head 2 < 1
  Flushing 7 2
  Chest discomfort 5 1
  Tightness in chest 3 < 1
  Pressure in chest 2 < 1
Ear, nose, and throat
  Throat discomfort 3 < 1
  Discomfort: nasal cavity/sinuses 2 < 1
  Injection site reactiona 59 24
  Jaw discomfort 2 0
  Weakness 5 < 1
  Neck pain/stiffness 5 < 1
  Myalgia 2 < 1
  Dizziness/vertigo 12 4
  Drowsiness/sedation 3 2
  Headache  2 < 1
  Sweating 2 1
a Includes injection site pain, stinging/burning, swelling, erythema, bruising, bleeding.

The incidence of adverse reactions in controlled clinical trials was not affected by gender or age of the patients. There were insufficient data to assess the impact of race on the incidence of adverse reactions.

Postmarketing Experience

The following adverse reactions have been identified during postapproval use of sumatriptan tablets, sumatriptan nasal spray, and sumatriptan injection. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.


Hypotension, palpitations


Dystonia, tremor

Read the entire FDA prescribing information for Zembrace SymTouch (Sumatriptan Succinate Subcutaneous Injection, USP)

© Zembrace SymTouch Patient Information is supplied by Cerner Multum, Inc. and Zembrace SymTouch Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors